Anton Vonk Noordegraaf
Overview
Explore the profile of Anton Vonk Noordegraaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
9894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luijten D, Rodenburg T, Bogaard H, Kianzad A, Ruigrok D, Croon P, et al.
PLoS One
. 2025 Feb;
20(2):e0317826.
PMID: 40009598
Introduction: Right heart catheterization (RHC) is the diagnostic standard for establishing residual pulmonary hypertension (PH) after pulmonary endarterectomy (PEA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). A potential non-invasive...
2.
Luijten D, van den Hout W, Boon G, Barco S, Bogaard H, Delcroix M, et al.
ERJ Open Res
. 2025 Jan;
11(1.
PMID: 39811556
Introduction: Achieving an early diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in pulmonary embolism (PE) survivors results in better quality of life and survival. Importantly, dedicated follow-up strategies to achieve...
3.
4.
Kovacs G, Humbert M, Avian A, Lewis G, Ulrich S, Vonk Noordegraaf A, et al.
Eur Respir J
. 2024 Nov;
64(6).
PMID: 39603672
Background: Exercise pulmonary hypertension (PH) was defined by a mean pulmonary arterial pressure (mPAP)/cardiac output (CO) slope >3 mmHg·min·L between rest and exercise in the 2022 European Society of Cardiology/European...
5.
Nossent E, Nossent G, Meijboom L, Verschuuren E, Gan C, Aman J, et al.
Am J Respir Crit Care Med
. 2024 Sep;
210(11):1370-1373.
PMID: 39288369
No abstract available.
6.
Hemnes A, Celermajer D, DAlto M, Haddad F, Hassoun P, Prins K, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209482
The right ventricle and its stress response is perhaps the most important arbiter of survival in patients with pulmonary hypertension of many causes. The physiology of the cardiopulmonary unit and...
7.
Cimini L, Luijten D, Barco S, Ghanima W, Jervan O, Kahn S, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 39076522
Introduction: Up to 50% of pulmonary embolism (PE) patients have perfusion defects or residual vascular obstruction during follow-up despite adequate anticoagulant treatment, and a similar percentage experience chronic functional limitations...
8.
Toth E, Celant L, Niglas M, Jansen S, Tramper J, Baxan N, et al.
Eur Respir J
. 2024 Jul;
64(4).
PMID: 38991711
Introduction: Pathogenic variants in the gene encoding for are a major genetic risk factor for heritable pulmonary arterial hypertension. Owing to incomplete penetrance, deep phenotyping of unaffected carriers of a...
9.
McLaughlin V, Sitbon O, Chin K, Galie N, Hoeper M, Kiely D, et al.
Eur J Heart Fail
. 2024 Jul;
26(11):2379-2391.
PMID: 38966990
Aims: According to current guidelines, initial monotherapy should be considered for pulmonary arterial hypertension (PAH) patients with cardiopulmonary comorbidities. This analysis of combined data from the TRITON and REPAIR clinical...
10.
Luijten D, Valerio L, Boon G, Barco S, Bogaard H, Delcroix M, et al.
Eur Respir J
. 2024 Jun;
64(4).
PMID: 38936968
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is often diagnosed late in acute pulmonary embolism survivors: more efficient testing to expedite diagnosis may considerably improve patient outcomes. The InShape II algorithm...